Related Experiment Videos
Chronic lymphocytic leukemia
Nicholas Chiorazzi1, Kanti R Rai, Manlio Ferrarini
1Institute for Medical Research, North Shore-LIJ Health System, Manhasset, NY 11030, USA. nchizzi@nshs.edu
The New England Journal of Medicine
|February 25, 2005
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
To Treat or Not to Treat: Navigating Early-Stage CLL in the Era of Targeted Therapy.
European journal of haematology·2026
Same author
Unfinished Business in Chronic Lymphocytic Leukemia: Translational and Clinical Priorities for a Cure.
Blood·2026
Same author
Updated consensus guidelines for the diagnosis and management of patients with HCL and HCL variant.
Blood·2026
Same author
Immunogenetic Architecture of Chronic Lymphocytic Leukemia at Early Stage: Insights from the O-CLL1 Cohort.
Antibodies (Basel, Switzerland)·2026
Same author
Intraclonal Enrichment of IL-23 Receptor Complex Expression in the Proliferative Fraction of Chronic Lymphocytic Leukemia.
International journal of molecular sciences·2026
Same author
IGLV3-21<sup>R110</sup>-directed bispecific antibodies activate T cells and promote killing in a high-risk subset of chronic lymphocytic leukemia.
Haematologica·2025
Same journal
Ebola at 50 - Lessons for Outbreak Response and Preparedness.
The New England journal of medicine·2026
Same journal
Ianalumab plus Eltrombopag in Immune Thrombocytopenia. Reply.
The New England journal of medicine·2026
Same journal
Ianalumab plus Eltrombopag in Immune Thrombocytopenia.
The New England journal of medicine·2026
Same journal
Hypertension Control in Low-Income Patients. Reply.
The New England journal of medicine·2026